# Intervertebral DXM Gel Injection in Adults With Painful Lumbar Degenerative Disc Disease

> **NCT04727385** · NA · UNKNOWN · sponsor: **Gelmetix** · enrollment: 20 (estimated)

## Conditions studied

- Degenerative Disc Disease
- Chronic Lower Back Pain
- Discogenic Pain
- Intervertebral Disc Degeneration
- Lumbar Disc Disease
- Lumbar Disc Degeneration
- Lumbar Disc Pain

## Interventions

- **DEVICE:** Double Crosslink Microgel

## Key facts

- **NCT ID:** NCT04727385
- **Lead sponsor:** Gelmetix
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-15
- **Primary completion:** 2021-10
- **Final completion:** 2021-10
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04727385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04727385, "Intervertebral DXM Gel Injection in Adults With Painful Lumbar Degenerative Disc Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04727385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*